UroGen's URO-102 May Offer Non-Surgical Option For Bladder Cancer Seeking Alpha, 27 Jul 2023 Summary UroGen Pharma's stock surged by 41% after successful trials of UGN-102, a treatment for non-muscle invasive bladder…